Table 4.
Top-18 pathways obtained for breast cancer subtypes after enrichment performed by MITHrIL.
| LumA | LumB | ||
|---|---|---|---|
| Pathway | -Value | Pathway | -Value |
| Chemokine signaling pathway | 0 | MAPK signaling pathway | 0 |
| HIF-1 signaling pathway | 0 | PI3K-Akt signaling pathway | 0 |
| VEGF signaling pathway | 0 | Apoptosis | 0 |
| Osteoclast differentiation | 0 | Neurotrophin signaling pathway | 0 |
| Hippo signaling pathway | 0 | Type I diabetes mellitus | 0 |
| Her2 | Basal | ||
| Pathway | -Value | Pathway | -Value |
| ErbB signaling pathway | 0 | Natural killer cell mediated cytotoxicity | 0 |
| Calcium signaling pathway | 0 | Chagas disease (American trypanosomiasis) | 0 |
| HIF-1 signaling pathway | 0 | HTLV-I infection | 0 |
| Focal adhesion | 0 | ||
| Adherens junction | 0 | ||